Log in to save to my catalogue

A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors

A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f199e800202e4de7bad91d4e281d2a23

A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors

About this item

Full title

A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2018-04, Vol.9 (1), p.1532-12, Article 1532

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Vaccines to induce effective and sustained antitumor immunity have great potential for postoperative cancer therapy. However, a robust cancer vaccine simultaneously eliciting tumor-specific immunity and abolishing immune resistance continues to be a challenge. Here we present a personalized cancer vaccine (PVAX) for postsurgical immunotherapy. PVAX...

Alternative Titles

Full title

A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f199e800202e4de7bad91d4e281d2a23

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f199e800202e4de7bad91d4e281d2a23

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-018-03915-4

How to access this item